The MUC1 promoter has been tested to control human somatostatin receptor subtype2 expression, a pro-apoptotic gene with anti-proliferative effects in MUC1 positive pancreatic cancer cells. This evidence concerns the gene MUC1 and pancreatic neoplasm.